Literature DB >> 17277798

The cellular world according to Hsp90.

Klaus Richter1, Linda M Hendershot, Brian C Freeman.   

Abstract

An international conference focusing on the Hsp90 molecular chaperone was recently held in Seeon, Germany. The program provided a current synopsis on a wide array of topics, including structural insights, roles in established and novel cellular pathways and disease implications.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17277798     DOI： 10.1038/nsmb0207-90

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN： 1545-9985            Impact factor:   15.369


  14 in total

1.  AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit.

Authors:  Tzu-Yin Lin; Joelle Fenger; Sridhar Murahari; Misty D Bear; Samuel K Kulp; Dasheng Wang; Ching-Shih Chen; William C Kisseberth; Cheryl A London
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

2.  Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.

Authors:  Asuka Ota; Jun Zhang; Peipei Ping; Jiahuai Han; Yibin Wang
Journal:  Circ Res       Date:  2010-03-18       Impact factor: 17.367

3.  Geldanamycin analog 17-DMAG limits apoptosis in human peripheral blood cells by inhibition of p53 activation and its interaction with heat-shock protein 90 kDa after exposure to ionizing radiation.

Authors:  Risaku Fukumoto; Juliann G Kiang
Journal:  Radiat Res       Date:  2011-06-10       Impact factor: 2.841

Review 4.  HSP90 manages the ends.

Authors:  Diane C DeZwaan; Brian C Freeman
Journal:  Trends Biochem Sci       Date:  2010-03-16       Impact factor: 13.807

5.  C1206, a novel curcumin derivative, potently inhibits Hsp90 and human chronic myeloid leukemia cells in vitro.

Authors:  Ying-Juan Fan; Yi-Xiang Zhou; Lian-Ru Zhang; Qiao-Fa Lin; Ping-Zhang Gao; Fang Cai; Li-Ping Zhu; Bi Liu; Jian-Hua Xu
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

6.  Hsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P-bodies.

Authors:  Justin M Pare; Nasser Tahbaz; Joaquín López-Orozco; Paul LaPointe; Paul Lasko; Tom C Hobman
Journal:  Mol Biol Cell       Date:  2009-05-20       Impact factor: 4.138

7.  Low concentration of GA activates a preconditioning response in HepG2 cells during oxidative stress-roles of Hsp90 and vimentin.

Authors:  Xuemei Chen; Hongyun Kang; Fei Zou
Journal:  Cell Stress Chaperones       Date:  2009-01-10       Impact factor: 3.667

Review 8.  Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivity.

Authors:  Annerleim Walton-Diaz; Sahar Khan; Dimitra Bourboulia; Jane B Trepel; Len Neckers; Mehdi Mollapour
Journal:  Future Med Chem       Date:  2013-06       Impact factor: 3.808

9.  The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors.

Authors:  Tzu-Yin Lin; Misty Bear; Zhenjian Du; Kevin P Foley; Weiwen Ying; James Barsoum; Cheryl London
Journal:  Exp Hematol       Date:  2008-07-26       Impact factor: 3.084

10.  The hsp90 molecular chaperone modulates multiple telomerase activities.

Authors:  Oyetunji A Toogun; Diane C Dezwaan; Brian C Freeman
Journal:  Mol Cell Biol       Date:  2007-10-22       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.